Biomarkers to improve PSA-cancer screening.
نویسندگان
چکیده
© The Canadian Journal of UrologyTM; 20(1); February 2013 Address correspondence to Dr. Kevin C. Zorn, University of Montreal Health Center (CHUM), 235, boul. René-Levesque Est, suite 301, Montreal, QC, H2X 1N8 Canada Biomarkers to improve PSA-cancer screening Kevin C. Zorn, MD, Mounsif Azizi, MD Section of Urology, Department of Surgery, University of Montreal Health Center, Montreal, Quebec, Canada
منابع مشابه
PSA Screening in Prostate Cancer
Introduction: Prostate cancer is one of the most common cancers in Iranian men. PSA(prostate specific antigen) screening is a controversial issue because PSA screening leads to diagnose of patients with low risk prostate cancer who not only do not benefit from treatment but also suffer from complication caused by treatment. On the other hand, without prostate cancer screening, the rate of meta...
متن کاملProjecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer.
BACKGROUND New biomarkers for early detection of cancer must pass through several phases of development. Early phases provide information on diagnostic properties but not on population benefits and harms. Prostate cancer antigen 3 (PCA3) is a promising prostate cancer biomarker still in early development. We use simulation modeling to project the impact of adding PCA3 to prostate-specific antig...
متن کاملDetection of prostate cancer by an FDG-PET cancer screening program: results from a Japanese nationwide survey
Objective(s): The aim of this study was to analyze detection rates and effectiveness of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program for prostate cancer in Japan, which is defined as a cancer-screening program for subjects without known cancer. It contains FDG-PET aimed at detection of cancer at an early stage with or without additional screening tests ...
متن کاملIs an improved PSA screening test in sight?
A fter decades of searching for a replacement for prostate-specific antigen (PSA) in prostate cancer screening, many researchers are once again examining variations on the long-beleaguered biomarker. PSA has withstood years of skepticism from critics who blame it for the overdiag-nosis and overtreatment of millions of men since it became the favorite prostate cancer screening test in the early ...
متن کاملWhat is the most appropriate test in detecting prostate cancer in patients with intermediate prostate specific antigen levels?
Abstract Background: Regarding the variety of tests present for detecting and also screening prostate cancer and also bearing in mind the advantages and disadvantages of these tests we decided to re-evaluate these tests (total prostate specific antigen and all of its modifications) in detecting prostate cancer in men with intermediate serum PSAlevels. Methods: Following a cross se...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Canadian journal of urology
دوره 20 1 شماره
صفحات -
تاریخ انتشار 2013